Hani Salehi-Had MD

11/13/2025

FDA Clears Gene Therapy Trial for GA.

The FDA has approved the initiation of the Opti-GAIN phase 1/2 clinical trial for CTx001, an adeno-associated virus (AAV)-based gene therapy targeting geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Developed by Complement Therapeutics, CTx001 delivers a truncated versio...

11/11/2025

We thank you for your commitment and celebrate your service.

11/11/2025

EyeCon 2025: The latest on treating ocular surface and cornea disease.

Rahul Tonk, MD, MBA a cornea, cataract, and refractive surgeon from Princeton Eye Group and faculty at Wills Eye Hospital, shared insights on recent advancements in ocular surface disease (OSD) for the EyeCon 2025 conference in Hollywood, Florida. Tonk and Joseph Allen, OD, FAAO, Dipl ABO, gave thei...

11/06/2025

Navigating MacTel From Diagnosis to Therapy.

Macular telangiectasia type 2 (MacTel) is a chronic, progressive, bilateral macular dystrophy that primarily affects individuals in midlife. Characterized by insidious central vision loss and retinal degeneration, it often goes undiagnosed until advanced stages. Recent advancements, such as the appr...

11/04/2025

The #1 Step to Preserve Your Vision With Macular Degeneration.

Age-related macular degeneration (AMD) can cause central vision loss but not complete blindness. Early diagnosis through regular eye exams can slow the progression of AMD.

10/30/2025

Navigating Optogenetics in the IRD Pipeline.

Optogenetics is emerging as a promising gene therapy for advanced inherited retinal diseases (IRDs) like retinitis pigmentosa, Stargardt disease, and Leber congenital amaurosis. By introducing light-sensitive opsins into surviving retinal cells, this approach aims to restore visual function even in....

10/28/2025

A soft micron accuracy robot design and clinical validation for retinal surgery.

Retinal surgery is one of the most delicate and complex operations, which is close to or even beyond the physiological limitation of the human hand. Robots have demonstrated the ability to filter hand tremors and motion scaling which has a promising output in microsurgery. Here, we present a novel s...

10/23/2025

AI Without Borders.

The Global RETFound initiative is a groundbreaking international collaboration aimed at addressing health inequities in ophthalmology. Spearheaded by researchers from institutions such as Moorfields Eye Hospital and University College London, the project seeks to create the world’s first globally ...

10/15/2025

Study maps intricate muscle patterns behind blinking and eyelid movement.

A blink of an eye seems natural and instantaneous, but is it? Without a functioning eyelid, the eye can become dry, irritated and eventually lose the ability to see clearly. Now, a team of UCLA biomechanical engineers and ophthalmologists has uncovered new details about the muscle that controls blin...

10/08/2025

New study compares the effects of low-level red light with 0.01% atropine treatment on axial length and choroid in myopic children.

An investigative team led by first author Xuena Pang, MD, reported their experience with the use of red light in children with myopia. They reported that 6 months of treatment showed that repeated low-level red light (RLRL) application was more effective than 0.01% atropine for controlling axial elo...

10/01/2025

What is hyperemic conjunctivitis?

Hyperemic conjunctivitis (HC) or “conjunctival hyperemia” refers to redness of the conjunctiva, the thin, transparent membrane that covers the white of the eye. Other names for HC include “red eye” or “pink eye”.

09/24/2025

Amblyopia (lazy eye) treatment: Eye patching, drops, digital therapies and more.

Amblyopia, also known as "lazy eye," is a common eye condition in kids that develops when a child has an eye that does not see well. This is caused by a poor connection between the eye to the brain, which can happen for a variety of different reasons. Amblyopia is more common in one eye but can also...